Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Cost of Healthcare

Thursday Links

Posted on December 29, 2023December 29, 2023 by John C. Goodman

The cost of developing a newly approved drug is $2.4–$3.2 billion, including the cost of drugs that fail.

Study finds that private equity purchased hospitals have a small decrease in patient morality, but a large increase in medical errors.

An earlier study found that private equity purchased hospitals had fewer patient deaths and no change in the quality of care.

+

How Long Do You Want to live… with Alzheimer’s?

Posted on December 27, 2023 by Devon Herrick

Several close family members developed Alzheimer’s or another form of dementia before they died. They all required institutional care. Alzheimer’s is an insidious disease that robs the victims of the person they were. It robs them of the people they loved as they forget the names and faces of family and friends. It robs them of their dignity as they can no longer care for themselves and must be fed, bathed, clothed and toileted like a toddler. It sometimes robs them of their legacy, as their care is so costly they have to bankrupt themselves before qualifying for Medicaid coverage.

+

Wednesday Links

Posted on December 27, 2023December 27, 2023 by John C. Goodman
  • To stay healthy, eat nuts, beans and whole grains.
  • Can germs be good for you? One study says yes.
  • Drug shortages are affecting half a million consumers. The problem has persisted for more than 20 years.
  • Rep. Dan Crenshaw’s bill would abolish “disparate treatment based on ethnicity or creed” and “compelled speech” at colleges and universities that receive federal money.
  • The US has the highest maternal mortality rate among developed countries. Could lack of civility and empathy be the reason?
+

Counterfeit Weight Loss Drugs Endanger Patients and Profits

Posted on December 26, 2023 by Devon Herrick

Semaglutide is in short supply. That is the generic name for a weight loss drug from the class of glucagon-like peptide 1 (GLP-1) receptor agonists. You may have heard of them under the brand names, Ozempic, Rybelsus, and Wegovy. Injections are taken weekly, and a month’s supply is around $1,400 if paying cash with a GoodRx coupon. Semaglutide is also prescribed for diabetes that does not respond to other treatments. Obese patients can expect to lose anywhere from 15% to 20% of their body weight. That is why it is in high demand and supplies are tight. The drug class is new and it works. Food cravings fall and patients report forgetting to eat. Oprah even admitted taking it.

+
  • Previous
  • 1
  • …
  • 228
  • 229
  • 230
  • 231
  • 232
  • 233
  • 234
  • …
  • 392
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom